Exact Mass: 377.2579326
Exact Mass Matches: 377.2579326
Found 227 metabolites which its exact mass value is equals to given mass value 377.2579326
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Karacoline
C22H35NO4 (377.25659500000006)
Karakoline is an organonitrogen heterocyclic compound that is aconitane bearing hydroxy groups at the 1alpha, 8, and 14alpha positions and substituted at on the nitrogen and at positions 4 and 16beta by ethyl, methyl, and methoxy groups, respectively. It has a role as a phytotoxin. It is a tertiary amino compound, a tertiary alcohol, a secondary alcohol, an alkaloid, an organonitrogen heterocyclic compound and a bridged compound. It derives from a hydride of an aconitane. Carmicheline is a natural product found in Aconitum karakolicum, Euglena gracilis, and Aconitum carmichaelii with data available. Origin: Plant; Formula(Parent): C22H35NO4; Bottle Name:Karakoline hydrochloride; PRIME Parent Name:Karakoline; PRIME in-house No.:V0337; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
NCIOpen2_008730
C23H39NO3 (377.29297840000004)
17-(Bis(2-hydroxyethyl)amino)androst-5-en-3-ol
C23H39NO3 (377.29297840000004)
Famprofazone
Famprofazone belongs to the family of Phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Arachidonoyl Serinol
C23H39NO3 (377.29297840000004)
2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain, and has been characterized as the natural endocannabinoid ligand for the CB1 receptor (PMID: 8954083, 9399597). Replacement of the sn-2 oxygen in the glycerol moiety of 2-AG with a nitrogen atom gives arachidonoyl serinol (PMID: 8893848). Arachidonoyl serinol is much more stable than 2-AG. However, it is at least a log less potent as a CB1 receptor agonist than 2-AG (PMID: 9399597). 2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain, and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.1,2 Replacement of the sn-2 oxygen in the glycerol moiety of 2-AG with a nitrogen atom gives arachidonoyl serinol.3 Arachidonoyl serinol is much more stable than 2-AG. However, it is at least a log less potent as a CB1 receptor agonist than 2-AG. [HMDB]
N-Linoleoyl Proline
C23H39NO3 (377.29297840000004)
N-linoleoyl proline belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Proline. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Proline is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Proline is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
5-Fluoro-adb, (+/-)-
(5alpha,17beta)-17-Benzoyl-4-azaandrost-1-en-3-one
Quilostigmine
Aconosine
C22H35NO4 (377.25659500000006)
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
4-(1-phenylethyl)-n-[4-(1-phenylethyl)phenyl]aniline
(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-4,11-dimethyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-methyllycoposerramine-T
6beta-acetoxy-9alpha-hydroxy-13(14)-labden-16,15-amide|vitexlactam A
C22H35NO4 (377.25659500000006)
20-ethyl-1alpha,6beta,8-trihydroxy-4-methyl-heteratisan-14-one|Hetereophyllidin|O1-demethyl-heteratisine
Karakoline
C22H35NO4 (377.25659500000006)
An organonitrogen heterocyclic compound that is aconitane bearing hydroxy groups at the 1alpha, 8, and 14alpha positions and substituted at on the nitrogen and at positions 4 and 16beta by ethyl, methyl, and methoxy groups, respectively. Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.396 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.391
MLS002153956-01!Karakoline39089-30-0
C22H35NO4 (377.25659500000006)
AA dihydroxypropylamine
C23H39NO3 (377.29297840000004)
Famprofazon
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
NA 23:4;O2
C23H39NO3 (377.29297840000004)
N-Ethyl-N,N-dimethyl-1-hexadecanaminium bromide
C20H44BrN (377.26569240000003)
Tetrabutylphosphonium benzotriazol-1-ide
C22H40N3P (377.29596900000007)
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate
HEXADECANOIC ACID 2-NITROPHENYL ESTER
C22H35NO4 (377.25659500000006)
sodium N-methyl-N-(1-oxooctadecyl)aminoacetate
C21H40NNaO3 (377.2905730000001)
N,N,N-Tripentyl-1-pentanaminium bromide
C20H44BrN (377.26569240000003)
(2-hexadecoxy-2-oxoethyl)-trimethylazanium,chloride
C21H44ClNO2 (377.30603940000003)
GR 46611
GR-46611 is a 5-HT1D receptor agonist. GR-46611 can be used in the research of bladder hyperactivity, leukemia[1][3].
1-O-tert-butyl 4-O-ethyl 4-[(4-methoxyphenyl)methyl]piperidine-1,4-dicarboxylate
9-hexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
C24H32BNO2 (377.25259619999997)
Morazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
1-(6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[D]azepin-7-YL)oxy)pyridin-3-YL)pyrrolidin-2-one
Carmegliptin
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
1-[3-(4-Morpholinyl)propylamino]-3-propan-2-yl-4-pyrido[1,2-a]benzimidazolecarbonitrile
5-Tert-butyl-7-(4-ethyl-1-piperazinyl)-2-methyl-3-phenylpyrazolo[1,5-a]pyrimidine
L-Phenylalanyl-L-isoleucyl-L-valine
C20H31N3O4 (377.23144460000003)
6beta-(Dimethylamino)-3beta,5-dihydroxy-5alpha-pregnan-20-one
C23H39NO3 (377.29297840000004)
[(2S,3R,4E,14Z)-2-amino-3-hydroxyoctadeca-4,14-dienyl] dihydrogen phosphate
C18H36NO5P (377.23309760000006)
7-[(4-Methyl-1-piperazinyl)methyl]-5-(phenylmethoxymethyl)-8-quinolinol
17beta-[Bis(2-hydroxyethyl)amino]androst-5-en-3beta-ol
C23H39NO3 (377.29297840000004)
12-(Phosphonooxy)octadecanoate(3-)
C18H34O6P-3 (377.20928940000005)
1-[2-Hydroxy-3-[4-(2-methylbutan-2-yl)phenoxy]propyl]-4-piperidinecarboxylic acid ethyl ester
C22H35NO4 (377.25659500000006)
N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-(3,5-dimethyl-1-pyrazolyl)acetamide
(8E,10Z,14E,16Z,18E)-7,13,20-trihydroxydocosa-8,10,14,16,18-pentaenoate
C22H33O5- (377.23278680000004)
(8Z,10E,14E,16Z,19Z)-7,12,13-trihydroxydocosa-8,10,14,16,19-pentaenoate
C22H33O5- (377.23278680000004)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
[(8S,9S,10R)-6-(cyclopropylmethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
1-[(3aR,4R,9bS)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
1-[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
1-[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
1-[(3aS,4S,9bR)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
[(8R,9R,10S)-6-(cyclopropylmethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
(9E,11E,14E,16Z,19Z)-7,8,13-trihydroxydocosa-9,11,14,16,19-pentaenoate
C22H33O5- (377.23278680000004)
(14E,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoate
C22H33O5- (377.23278680000004)
(7S,15E,17S,19Z)-7,8,17-trihydroxydocosa-9,11,13,15,19-pentaenoate
C22H33O5- (377.23278680000004)
(1S,2R,3R,5S,6S,8S,9S,13R,16S,17R)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
2-(6-methoxypyridin-2-yl)-4-pyrrolidin-1-yl-1-[[(2R)-pyrrolidin-2-yl]methyl]benzimidazole
(1alpha,5xi,9xi,10xi,14alpha)-20-Ethyl-1,16-dimethoxyaconitane-8,14-diol
C22H35NO4 (377.25659500000006)
N-Isobutyl 9-(para-phenoxyphenyl)-2,4-nonadienamide
Famprofazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
N-arachidonoyl dihydroxypropylamine
C23H39NO3 (377.29297840000004)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate
A docosanoid anion that is the conjugate base of 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
sphingadienine-1-phosphate
C18H36NO5P (377.23309760000006)
A sphingoid 1-phosphate that is sphingadienine substituted by a phospho group at position 1.
(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate
A docosanoid anion that is the conjugate base of (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T1(1-)
A docosanoid anion that is the conjugate base of resolvin T1, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T2(1-)
A docosanoid anion that is the conjugate base of resolvin T2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T3(1-)
A docosanoid anion that is the conjugate base of resolvin T3, obtained by deprotonation of the carboxy group; major species at pH 7.3.
SPHP(19:1)
C19H40NO4P (377.2694810000001)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MCU-i4
MCU-i4 blocks the IP3-dependent mitochondrial Ca2+-uptake, maintaining the gatekeeping role of their target[1][2].
1-hydroxy-2-methyl-3-(3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl)quinolin-4-one
(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dodec-2-enimidic acid
(5s,6s,8s,10r,13r)-11-ethyl-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol
C22H35NO4 (377.25659500000006)
(1r,2s,5r,8r,9r,10r,11s,12r,13s,15r,16r)-7-ethyl-12-(hydroxymethyl)-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,12-triol
C22H35NO4 (377.25659500000006)
(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
n-[2-(4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
alginine
C23H39NO3 (377.29297840000004)
{"Ingredient_id": "HBIN015127","Ingredient_name": "alginine","Alias": "NA","Ingredient_formula": "C23H39NO3","Ingredient_Smile": "NA","Ingredient_weight": "377.566","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7038","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,3s,6r,9s,10r,11r,14r,17s,18r,19s)-12-ethyl-9,17,19-trihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one
(1r,2s,3r,4s,5s,8s,9s,10r,13r,16s,17r)-11-ethyl-16-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-2,4,8-triol
C22H35NO4 (377.25659500000006)
(1s,2r,3r,4r,5s,6s,8s,9r,10s,13s,16r,17s)-11-ethyl-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol
C22H35NO4 (377.25659500000006)
(1r,4r,5r,8r,9r,10r,11s,12r,13s,15s,16s)-7-ethyl-12-(hydroxymethyl)-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-4,11,12-triol
C22H35NO4 (377.25659500000006)
(1s,2r,3r,4s,5r,6r,8s,9s,10r,13r,16s,17r)-11-ethyl-16-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8-triol
C22H35NO4 (377.25659500000006)
n-(4-hydroxy-2-{[(11-methyldodecyl)oxy]carbonyl}phenyl)ethanimidic acid
C22H35NO4 (377.25659500000006)
n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dodec-2-enimidic acid
(9s,13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,9,13-trihydroxytridecan-4-one
C18H35NO7 (377.24134000000004)
(8r,12s)-6-hydroxy-8-phenyl-1,5,9-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-5,13,15,17-tetraen-19-one
13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,9,13-trihydroxytridecan-4-one
C18H35NO7 (377.24134000000004)
2-(4,8-dimethylnona-1,3,7-trien-1-yl)-2,5-dimethyl-3h,4h-pyrano[3,2-c]quinolin-6-ium-6-olate
(1s,2s,8s,9s)-9-{[2-(1h-indol-3-yl)ethyl]amino}-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]pentadec-11-en-13-one
(3s,5s)-5-[(3s,9r,9as)-9-[(1s)-1-[(2r,4s)-4-methyl-5-oxooxolan-2-yl]propyl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one
C22H35NO4 (377.25659500000006)
(6s,8s)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
(7s,12r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-9,13,15,17-tetraen-19-one
12-ethyl-9,17,19-trihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one
7-ethyl-12-(hydroxymethyl)-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-4,11,12-triol
C22H35NO4 (377.25659500000006)
11-ethyl-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol
C22H35NO4 (377.25659500000006)
(1s,3s,4s,4ar,8ar)-4-hydroxy-4-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
C22H35NO4 (377.25659500000006)
3-{[(3e,6e,8e,10r,11r,12e)-1,11-dihydroxy-4,8,10,12-tetramethyltetradeca-3,6,8,12-tetraen-1-ylidene]amino}butanoic acid
C22H35NO4 (377.25659500000006)
3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3,5-dimethylpyrano[2,3-c]quinolin-6-ium-6-olate
6-hydroxy-8-phenyl-1,5,9-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-5,13,15,17-tetraen-19-one
9-{[2-(1h-indol-3-yl)ethyl]amino}-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]pentadec-11-en-13-one
2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,5-dimethylpyrano[3,2-c]quinolin-6-ium-6-olate
n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dodec-2-enimidic acid
2-(4,8-dimethylnona-3,7-dien-1-yl)-2,5-dimethylpyrano[3,2-c]quinolin-6-ium-6-olate
(2r,3r,4s,5s,6s,8s,13r,16s,17r)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
9-hydroxy-7-phenyl-1,6,10-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-9,13,15,17-tetraen-19-one
2-[(1e,3e)-4,8-dimethylnona-1,3,7-trien-1-yl]-2,5-dimethyl-3h,4h-pyrano[3,2-c]quinolin-6-ium-6-olate
(1r,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol
C22H35NO4 (377.25659500000006)
(3s,5s)-5-[(3s,9r,9as)-9-[(1r)-1-[(2r,4s)-4-methyl-5-oxooxolan-2-yl]propyl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one
C22H35NO4 (377.25659500000006)
3-(4,8-dimethylnona-3,7-dien-1-yl)-3,5-dimethylpyrano[2,3-c]quinolin-6-ium-6-olate
7-ethyl-12-(hydroxymethyl)-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,12-triol
C22H35NO4 (377.25659500000006)
3-methyl-5-{9-[1-(4-methyl-5-oxooxolan-2-yl)propyl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl}oxolan-2-one
C22H35NO4 (377.25659500000006)
(1r,2s,5r,8r,9r,10r,11s,12r,13s,15s,16r)-7-ethyl-12-(hydroxymethyl)-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,12-triol
C22H35NO4 (377.25659500000006)
(1s,2r,3r,4s,5s,6s,8s,13r,16s,17r)-11-ethyl-6-methoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol
C22H35NO4 (377.25659500000006)
(1s,2s,3s,4s,5r,6s,8r,9r,10s,13s,16s,17s)-11-ethyl-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol
C22H35NO4 (377.25659500000006)
1-hydroxy-2-methyl-3-[(2e,4e,6e)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]quinolin-4-one
4-hydroxy-4-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
C22H35NO4 (377.25659500000006)